PPARG and metabolic dysfunction-associated steatotic liver disease: These findings indicate that by regulating PPAR-γ in macrophages to balance the M1/M2 phenotype of metabolically activated macrophages, thus affecting their interaction with HSCs, it may influence hepatic oxidative stress, steatosis, inflammation, and fibrosis during NAFLD progression (Kratz et al., 2014).